Ụlọ - Akwụkwọ edemede
Usoro Eclectic Novel maka ọgwụgwọ ọrịa kansa yana mma mma mmiri na ọgwụ mgbochi: UMIPIC, ọ nwere ike gafere ọtụtụ ịwa ahụ, kemoterapi na ọgwụgwọ radieshon maka ọkwa niile nke Tumor siri ike.
Ngwakọta ọgwụ nke H2 O2 Injection Intratumoral jikọtara iji tụgharịa Matrix Extracellular ka ọ bụrụ Coagulum autologous dị ka ebe nchekwa ọgwụ.
Olileanya ọhụrụ maka ọgwụgwọ ọrịa kansa yana mma mma mmiri na ọgwụgwọ immuno: UMIPIC
Mbufụt Tumor na CD4/8+ na CD11+ emelitere Ogologo Ịlanahụ Ogologo oge n'ọkwa dị elu nke etuto siri ike niile site na Ultra Minimum Incision ahaziri Intratumoral Chemoimmunotehrapy
Mbufụt na-egbu egbu nwere nkwupụta pụrụ iche nke CD11 & CD4 na-ebute mmetụta Abscopal site na Intramoral Injection Chemotherapy Drug with Hapten in Animal Model
Oge Ọhụrụ nke ịwa ahụ lmmuno na-abịa: Usoro Eclectic Novel maka ọgwụgwọ ọrịa kansa site na iji mma mma na ọgwụgwọ lmmuno
Mbufụt Tumor dị ukwuu na CD4/8+ na CD11+ Na-agbatị Mmetụta Ịlanahụ nke Intratumral Injection Na-akpata Nchikota Ọgwụ Chemotherapy na Hydralazine dị ka Ememe na Ụdị anụmanụ.
Kweere mkpụrụ ndụ na-alụso ọrịa ọgụ site na Hapten Enhanced Intratumoral Chemotherapy na Penicillin na-agbatị ndụ kansa Pancreatic.
Ezubere iche nke ọma n'ọnọdụ antigen nuklia oncogenic site na butere tumor metụtara autoantibodies (iTAA)
Mgbanwe ndị na-alụso ọrịa ọgụ nke Intratumoral Hapten Plus Chemotherapy na-ebute Ọgwụ nke EndometrialCancer.
Nkwadebe ọrịa mgbochi ọrịa kansa yana ịgbalite mkpụrụ ndụ mgbochi site na chemotherapy emelitere nke ọma na ọrịa kansa akpa ume mbụ.
Nchikota mgbochi mgbochi kemịkalụ nke ọnya cervical precancer na-akpọte sel ndị na-alụso ọrịa ọgụ ma weghachite HPV na-adịghị mma na nke na-adịghị mma.
Mmetụta sodium stibogluconate na iwere na ịkpọlite mkpụrụ ndụ na-alụso ọrịa ọgụ na mmiri pleural nke ọrịa kansa pancreatic: nkwadebe maka immunotherapy.
Jiri Profaịlụ scRNA-Seq kọwapụta azịza Immunologic mgbe Intra-tumor na-eme ka Chemotherapy dịkwuo mma n'ihe gbasara Intracranial Anaplastic Hemangiopericytoma Imeju Metastasis: Akụkọ Ikpe
Usoro ọgwụgwọ ọgwụ kemịkalụ nke Hapten-Mediated na nchịkwa ọgwụ n'ime cervical cancer na-enweghị hysterectomy: Mkpọlite mkpụrụ ndụ mgbochi maka ọgwụ mgbochi ọrịa.
Nchọpụta biomarker na hepatocellular carcinoma (HCC) maka ọgwụgwọ ahaziri onwe ya na mmụba amụma.